Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) shares were up 16.7% on Monday . The stock traded as high as $0.38 and last traded at $0.35. Approximately 74,167 shares changed hands during trading, an increase of 77% from the average daily volume of 41,982 shares. The stock had previously closed at $0.30.
Alpha Tau Medical Stock Up 16.7 %
The stock’s 50 day moving average is $0.30 and its two-hundred day moving average is $0.23.
About Alpha Tau Medical
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.
Further Reading
- Five stocks we like better than Alpha Tau Medical
- Investing in Travel Stocks Benefits
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- How to Calculate Stock Profit
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- ESG Stocks, What Investors Should Know
- Conflicting Signals: Tempus AI’s Stock Market Rally
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
